The emergence of multidrug resistance (MDR) in malignant tumors is one of the leading
threats encountered currently in many chemotherapeutic agents. The overexpression of the …

Dendrimers are a family of polymers with highly branched structure, well‐defined
composition, and extensive functional groups, which have attracted great attention in …

Gene silencing by RNA interference represents a promising therapeutic approach. The
development of carriers, eg, polymers, lipids, peptides, antibodies, aptamers, small …

The alliance between nanomaterials and cancer therapy has revolutionized the treatment of
tumor patients. After cardiovascular diseases, cancer is the leading cause of death, so …

Nowadays, the targeted imaging probe and drug delivery systems are the novel
breakthrough area in the nanomedicine and treatment of various diseases. Conjugation of …

Therapeutic oligonucleotides (TOs) represent one of the most promising drug candidates in
the targeted cancer treatment due to their high specificity and capability of modulating …

Nanomedicine is a field that combines biology and engineering to improve disease
treatment, particularly in cancer therapy. One of the promising techniques utilized in this …

With the continuous increasing number of cancer patients worldwide, there has been great
interest in developing the targeted delivery anti-cancer drugs. The drug concentration …

Gene therapy can be used as a cancer therapy by affecting signaling networks participating
in the aggressive behavior of tumors. Small interfering RNA (siRNA) is a genetic tool …

Neutrophil extracellular traps (NETs) are structures consisting of decondensed chromatin
with associated proteins, including histones and antimicrobial peptides, released from …